New re­port digs in­to top block­busters and their re­liance on patents to block com­pe­ti­tion

3 years ago
Pharma
Law

A month af­ter GSK's win in Zan­tac can­cer case, plain­tiffs file dozens more suits

3 years ago
Law

J&J ex­pands in Ire­land with a $100M+ in­vest­ment for con­tact lens man­u­fac­tur­ing site

3 years ago
Manufacturing

No­vo Nordisk ex­ecs had on­ly one drug on their mind when they came call­ing at For­ma. Here's the in­side sto­ry of their ...

3 years ago
Deals

Along­side promis­ing first HAE da­ta, In­tel­lia posts read­out in Re­gen­eron-part­nered AT­TR pro­gram

3 years ago
R&D

Pal­isade Bio is the lat­est to re­struc­ture, hun­ker­ing down on its lead pro­gram

3 years ago
People
R&D

Scoop: Ab­b­Vie, Bris­tol My­ers bring out the bud­get axe, out­lin­ing plans to lay off more than 350 West Coast em­ploy­ees

3 years ago
People
Pharma

In­tel­lia presents a promis­ing snap­shot of its first da­ta for once-and-done in vi­vo CRISPR treat­ment for HAE

3 years ago
R&D

Catch­ing up with Mer­ck in ad­ju­vant melanoma, Bris­tol My­ers bur­nish­es Op­di­vo pro­file in ear­li­er stages of can­cer

3 years ago
R&D
Pharma

Biden di­rec­tive on screen­ing for­eign in­vest­ments in US biotech not tar­get­ed at Chi­na, ad­min of­fi­cials say

3 years ago
China
Law

That $930M drug Alex­ion bought to pair with Soliris, Ul­tomiris? As­traZeneca says it just aced a PhI­II test

3 years ago
R&D

Scor­pi­on snags a Sanofi vet to lead the way to the clin­ic; All eyes on eli-cel as blue­bird seeks a fi­nance leader — ...

3 years ago
Peer Review

Lancet com­mis­sion sharply cri­tiques WHO and gov­ern­ments over their Covid re­sponse

3 years ago
Coronavirus

Gilead aims to dri­ve health eq­ui­ty through ed­u­ca­tion eq­ui­ty with new $20M fund

3 years ago
Pharma
Marketing

Van­da sues FDA yet again, ac­cus­es fed­er­al agency of de­lay­ing post-CRL hear­ing

3 years ago
FDA+
Law

Illi­nois phar­ma com­pa­ny to pay al­most $8M af­ter sell­ing OTC drugs un­der ob­so­lete pre­scrip­tion-on­ly la­bels

3 years ago
Pharma
Law

Sen­a­tors ques­tion how HHS plans to roll out new drug pric­ing re­forms

3 years ago
Pharma
Law

No­var­tis files an­oth­er FDA pe­ti­tion to halt En­tresto com­pe­ti­tion as block­buster fight ap­proach­es

3 years ago
FDA+

Man­u­fac­tur­ing roundup: WuXi STA un­veils new fa­cil­i­ty; Pur­due Uni­ver­si­ty nets $3M grant for ze­ro-waste phar­ma ...

3 years ago
Manufacturing

As­traZeneca and peo­ple who are im­muno­com­pro­mised, in­clud­ing celebs, re­mind us they're 'still here’ in new Covid ...

3 years ago
Pharma
Marketing

Fu­ji­film Diosynth breaks ground on a $1.6B ex­pan­sion project in Den­mark

3 years ago
Cell/Gene Tx
Manufacturing

NIH pumps $130M in­to health and med­i­cine AI re­search

3 years ago
R&D

Trou­bled times: With its back against the wall, lit­tle Tenax sends out an SOS while IMV takes out the bud­get axe, ...

3 years ago
People
Pharma

Mallinck­rodt se­cures FDA ap­proval — but not with­out warn­ing; Rhythm seeks $100M af­ter reg­u­la­to­ry OKs

3 years ago
News Briefing
First page Previous page 463464465466467468469 Next page Last page
A service from the Financial Times